Beximco Pharmaceuticals Ltd. is a leading pharmaceutical company based in Bangladesh. Founded in 1976, it is part of the Beximco Group, one of the largest conglomerates in the country. Beximco Pharmaceuticals is known for producing a wide range of generic medicines, active pharmaceutical ingredients (APIs), and healthcare products, catering to both domestic and international markets.
Some key highlights about Beximco Pharmaceuticals include:
-
Product Portfolio: The company manufactures a wide variety of pharmaceutical products, including those for cardiovascular, dermatology, oncology, anti-infective, gastrointestinal, and respiratory diseases. It also produces over-the-counter (OTC) products and injectables.
-
International Market: Beximco is one of the top exporters of pharmaceuticals in Bangladesh. It exports products to more than 50 countries, including the United States, Europe, and various developing markets. The company holds several certifications, such as Good Manufacturing Practice (GMP), and operates in compliance with international standards.
-
Research and Development: Beximco focuses on R&D to develop new and cost-effective generic medicines, particularly targeting chronic diseases. The company has an extensive R&D division that works on improving existing formulations and developing new products.
-
Regulatory Approvals: The company has obtained approvals from global regulatory bodies, including the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the World Health Organization (WHO), enabling it to sell its products internationally.
-
Sustainability: Beximco Pharmaceuticals has been committed to sustainability and corporate social responsibility (CSR), contributing to healthcare development, environmental protection, and supporting education and community welfare.
